N/A
N=135
Comparison of Propofol and Sevoflurane as a Primary Anesthetic for Cardiac Ablation of Atrial Fibrillation.
Atrial Fibrillation
Bottom Line
View on ClinicalTrials.gov: NCT02697448 ↗Enrolled (actual)
135
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcome: Primary: Procedure Duration — 159.2; 170.7 minutes
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- propofol (Drug); sevoflurane (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Medical University of South Carolina
- Primary completion
- Jun 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Procedure Duration |
159.2; 170.7 | — |
| PRIMARY Time to Extubation |
11; 8 | — |
Summary
Comparison of propofol and sevoflurane as a primary anesthetic for cardiac ablation of atrial fibrillation
Eligibility Criteria
Inclusion Criteria
- have paroxysmal atrial fibrillation
- undergoing their first ablation.
Exclusion Criteria
- none
Data sourced from ClinicalTrials.gov (NCT02697448). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.